In order to confirm that BRD4 silencing caused miR-765-induced anti-ovarian cancer cell activity, an UTR-null BRD4 construct was transfected to lv-pre-miR-765-Stb-L1 pOC-1 cells (see Figures 1–3). The gene discussed is BRD4; the disease is ovarian carcinoma.